TCL Archive Congressional subcommittee criticizes NIH for lax conflict of interest policies. NIH Director Zerhouni promises change. The subcommittee has asked several NCI officials to testify at another hearing next week. May 14, 2004
TCL Archive Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials March 26, 1993
TCL Archive ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications July 22, 2011
